Ironwood Pharmaceuticals | IRWD - Операционный доход





Операционный доход Изменить Дата
Acadia Pharmaceuticals USD 37.84M 42.45M 2026-06
Agios Pharmaceuticals USD -110.02M 11.55M 2026-03
Akebia Therapeutics USD -5.45M 9.4M 2025-12
Almirall EUR 71.55M 41.32M 2026-06
Alnylam Pharmaceuticals USD 112.6M 24.99M 2026-06
Amarin USD -2.26M 564K 2025-12
Ardelyx USD -32.79M 37.89M 2026-03
Astellas Pharma JPY 185.36B 136.79B 2026-06
AstraZeneca USD 3.16B 3.95B 2026-06
Charles River Laboratories USD 119.89M 9K 2026-06
Coherus Biosciences USD -39.08M 3.65M 2025-12
Emergent BioSolutions USD -218M 69.9M 2023-06
Halozyme Therapeutics USD -63.72M 1.95M 2026-06
Incyte USD 700.4M 376.22M 2026-06
Ironwood Pharmaceuticals USD 33.22M 7.58M 2024-12
Karyopharm Therapeutics USD -26.76M 8.92M 2026-03
Lexicon Pharmaceuticals USD -14.78M 2.59M 2025-12
MacroGenics USD -33.44M 21.34M 2026-03
Moderna USD -815M 573M 2026-06
Myriad Genetics USD -3M 20.3M 2025-12
Pacira USD 9.96M 5.33M 2026-06
PTC Therapeutics USD 45.89M 127.51M 2026-03
Puma Biotechnology USD 22.08M 24.26M 2024-09
Sarepta Therapeutics USD 13.29M 345.14M 2026-06
Takeda JPY 201.42B 215.04B 2026-06
Ultragenyx Pharmaceutical USD -75M 141M 2026-06
Vanda Pharmaceuticals USD -40.66M 29.66M 2024-12